The Globe and Mail: Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
Donors giving blood plasma at Grifols’ paid collection centres are not informed that some medicines made from their donations will be sold for profit overseas, according to testimony from a Canadian ...
Grifols donors not informed their plasma is used for drugs sold overseas, MPs hear
Seeking Alpha on MSN: Grifols facing restrictions in Canada after plasma donor deaths
CNN: People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers
People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers
News Medical: Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers
Convalescent plasma can be donated by COVID-19 survivors at Grifols’ donor centers
Business Insider: People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around …
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further …
Spanish drugmaker Grifols SA is facing restrictions on its Canadian licence to collect blood products following the deaths of two patients who made plasma donations in the country. Health Canada, ...
Yahoo: Some paid plasma donors 'still pretty comfortable with doing it' after deaths
Add Yahoo as a preferred source to see more of our stories on Google. Deaths of paid plasma donors in Manitoba have sparked calls to ban the practice, but not everyone is on board. (CBC - image credit ...
Some paid plasma donors 'still pretty comfortable with doing it' after deaths
Add Yahoo as a preferred source to see more of our stories on Google. Health Canada says the Grifols plasma site on Taylor Avenue will be subject to a set of new conditions, but another on Innovation ...
Canadian health officials imposed restrictions on all plasma centers run by Grifols (GRFS) after the Spanish company failed multiple regulatory inspections and following fatal adverse reactions in two ...
CBC.ca: Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Winnipeg deaths
Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Winnipeg deaths
BARCELONA, Spain, Jan. 4, 2022 /PRNewswire/ -- Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and one of world's top producers of plasma-derived medicines, today announced ...
Grifols, a global healthcare company with a track record of more than 100 years and a recognized leader in the development and production of plasma-derived medicines, today announced it has begun ...
Add Yahoo as a preferred source to see more of our stories on Google. Health Canada says the Grifols plasma donation centre in Regina violated policy requiring at least a two-day gap between a person ...
The Globe and Mail: Health Canada imposes new conditions on Grifols after deaths of two people who donated plasma
Health Canada is imposing new terms and conditions on the licences of Grifols, Canada’s only major commercial collector of blood plasma, after two people died following donations in recent months. The ...
Health Canada imposes new conditions on Grifols after deaths of two people who donated plasma
Yahoo News UK: Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Manitoba deaths
Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Manitoba deaths
(KUTV) — Grifols is a global health-care company and a recognized leader in the development and production of plasma-derived medicines. They operate a network of more than 250 centers operating under ...
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ...
Descubre las innovadoras soluciones biofarmacéuticas y sanitarias integrales de Grifols centradas en el paciente.
Explore Grifols Poland, a leader in biotechnology and healthcare, dedicated to improving patient lives through innovative therapies and high-quality services.
Grifols is a global healthcare company that has enhanced the health and well-being of people around the world.
Join Grifols to create a lasting impact with your career. Explore opportunities that allow you to contribute to life-saving solutions and innovate for a healthier future.
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the first analysis laboratory in Barcelona: Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos.
Contact Grifols for inquiries and support. Our team is here to assist you with information and resources tailored to your needs.
Explore Grifols France for cutting-edge pharmacovigilance and comprehensive medical information to enhance patient safety and treatment outcomes.
Yahoo: 2 deaths after giving plasma in Winnipeg not linked to donation process: Health Canada
2 deaths after giving plasma in Winnipeg not linked to donation process: Health Canada
Health Canada has slapped new terms and conditions on all of a company's paid plasma centres after multiple failed inspections where the regulator found "recurring, systemic deficiencies." This comes ...
BARCELONA, Spain, /PRNewswire/ -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company with a track record of more than 100 years and a recognized leader in the ...
Add Yahoo as a preferred source to see more of our stories on Google. Health Canada says an inspection of Grifols's Canadian head office in Ontario found the company wasn't accurately assessing a ...
The sale of a minority stake of its U.S. Biopharma business by means of an initial public offering (IPO) would raise capital to strengthen the Group’s balance sheet, reduce debt and support investment in its strategic growth priorities, while allowing Grifols to maintain majority ownership of its U.S. Biopharma business The proposed transaction reinforces Grifols’ self-sufficiency vision ...